Poseida Therapeutics (PSTX) has issued an announcement.
Poseida Therapeutics, Inc. has released an important update on its genetic medicine research and development initiatives, accompanied by a corporate presentation. This new information, which includes insights from the company’s management and advisors, is now accessible to investors and the media on the company’s website. The announcement emphasizes that this material is for informational purposes and not for regulatory filing obligations.
Learn more about PSTX stock on TipRanks’ Stock Analysis page.
